???global.info.a_carregar???
Identificação

Identificação pessoal

Nome completo
ANA MARTA MARTINS VALENTE PINTO

Nomes de citação

  • Pinto, MV
  • Marta Valente Pinto
  • Valente Pinto, M

Identificadores de autor

Ciência ID
EE1D-5814-EF64
ORCID iD
0000-0002-9716-7848
Formação
Grau Classificação
2016/10/01 - 2021/06/30
Concluído
 DPhil in Paediatrics (Doctor of Philosophy)
Especialização em Vaccinology
University of Oxford, Reino Unido
2020/11/01 - 2021/06/01
Concluído
 Professional Diploma in Travel Health (Postgraduate Certificate)
Liverpool School of Tropical Medicine, Reino Unido
 Distinction
2014/09/01 - 2015/12/01
Concluído
 Harvard Medical School - Fundação para a Ciência e Tecnologia (FCT) - Portugal Program in Translational Research and Information (Especialização pós-licenciatura)
Fundação para a Ciência e a Tecnologia, Portugal
2009/01/01 - 2015/04/15
Concluído
 Especialista em Pediatria (Título de especialista)
Centro Hospitalar Lisboa Norte EPE, Portugal
 19.4
2009/09/01 - 2010/06/30
Concluído
 Doenças Infecciosas Emergentes (Pós-Graduação)
Universidade de Lisboa: Faculdade de Medicina, Portugal
 17
2001/09/01 - 2007/06/15
Concluído
 Licenciatura em Medicina (Licenciatura)
Universidade de Lisboa: Faculdade de Medicina, Portugal
 17
Percurso profissional

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento 		Empregador
2022/02/01 - Atual Professor Auxiliar (Docente Universitário) Egas Moniz Cooperativa de Ensino Superior CRL, Portugal
2007/09/01 - 2013/06/30 Assistente (Docente Universitário) Universidade de Lisboa: Faculdade de Medicina, Portugal

Outras Carreiras

Categoria Profissional
Instituição de acolhimento 		Empregador
2020/05/20 - Atual Assistente (Médica) Centro Hospitalar de Lisboa Central EPE, Portugal
2009/01/01 - 2015/05/01 Interno (Médica) Centro Hospitalar Lisboa Norte EPE, Portugal
Projetos

Outro

Designação Financiadores
2024/10/27 - 2025/10/01 Respiratory Syncytial Virus Mutational Profile during a Pharmacological Prophylactic Intervention
NA
Investigador responsável
Egas Moniz Cooperativa de Ensino Superior CRL, Portugal
 Sociedade Portuguesa de Pediatria
Em curso
Produções

Publicações

Artigo em revista
  1. Marta Valente Pinto; Alex-Mikael Barkoff; Sagida Bibi; Aapo Knuutila; Johanna Teräsjärvi; Elizabeth Clutterbuck; Sophie Gimenez-Fourage; et al. "A novel whole blood assay to quantify the release of T cell associated cytokines in response to Bordetella pertussis antigens". Journal of Immunological Methods (2024): http://dx.doi.org/10.1016/j.jim.2024.113758.
    10.1016/j.jim.2024.113758
  2. Joshua Gillard; Madeleine Suffiotti; Peter Brazda; Prashanna B. Venkatasubramanian; Pauline Versteegen; Marien de Jonge; Dominic Kelly; et al. "Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis". Nature Communications (2024): http://dx.doi.org/10.1038/s41467-024-46560-w.
    10.1038/s41467-024-46560-w
  3. Kushalinii Hillson; Jonathan Kantor; Marta Valente Pinto; Andrew J. Pollard; Dominic Kelly; Samantha Vanderslott; the AWARE clinical trial team. "Motivations for paediatric vaccine trial participation". Trials 24 1 (2023): http://dx.doi.org/10.1186/s13063-023-07597-2.
    10.1186/s13063-023-07597-2
  4. Inês Hormigo; Marta Valente Pinto; Ana Isabel Cordeiro; Cristina Henriques; Catarina Martins; João Parente Freixo; Marta Conde; Catarina Gouveia; João Farela Neves. "Hemophagocytic lymphohistiocytosis in an adolescent with NLRP12 related autoinflammatory disorder—A case report". Pediatric Allergy and Immunology 34 9 (2023): http://dx.doi.org/10.1111/pai.14020.
    10.1111/pai.14020
  5. Diana Simão Raimundo; Ana Isabel Cordeiro; João Parente Freixo; Marta Valente Pinto; Conceição Neves; João Farela Neves. "Case Report: Patient with deficiency of ADA2 presenting leukocytoclastic vasculitis and pericarditis during infliximab treatment". Frontiers in Pediatrics 11 (2023): http://dx.doi.org/10.3389/fped.2023.1200401.
    10.3389/fped.2023.1200401
  6. Pinto, Marta Valente; Neves, João Farela. "Precision medicine: The use of tailored therapy in primary immunodeficiencies". Frontiers in Immunology 13 (2022): http://dx.doi.org/10.3389/fimmu.2022.1029560.
    Acesso aberto • 10.3389/fimmu.2022.1029560
  7. Marta Valente Pinto; Pedro Simão Coelho; Catarina Gouveia; Conceição Neves; Ana Isabel Cordeiro; João Farela Neves. "Recurrent pyogenic infections caused by a novel Gln1420* mutation in the C3 gene". Frontiers in Pediatrics 10 (2022): http://dx.doi.org/10.3389/fped.2022.1017195.
    10.3389/fped.2022.1017195
  8. Versteegen, Pauline; Barkoff, Alex-Mikael; Valente Pinto, Marta; van de Kasteele, Jan; Knuutila, Aapo; Bibi, Sagida; de Rond, Lia; et al. "Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries". Frontiers in Immunology 13 (2022): http://dx.doi.org/10.3389/fimmu.2022.864674.
  9. Marta Valente Pinto; Pauline Versteegen; Alex-Mikael Barkoff; Jan van de Kasteele; Aapo Knuutila; Sagida Bibi; Lia de Rond; et al. "Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries". Frontiers in Immunology 13 (2022): http://dx.doi.org/10.3389/fimmu.2022.864674.
    10.3389/fimmu.2022.864674
  10. Coelho, Pedro Simão; Gouveia, Catarina; Pinto, Marta Valente; Neves, Conceição; Cordeiro, Ana Isabel; Neves, João Farela. "Recurrent pyogenic infections caused by a novel Gln1420* mutation in the C3 gene". (2022): http://hdl.handle.net/10362/145222.
    https://doi.org/10.3389/fped.2022.1017195
  11. Davis, Kimberly; Valente Pinto, Marta; Andrews, Nick J; Goldblatt, David; Borrow, Ray; Findlow, Helen; Southern, Jo; et al. "Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial". The Lancet Infectious Diseases 21 5 (2021): 688-696. http://dx.doi.org/10.1016/s1473-3099(20)30600-9.
    10.1016/s1473-3099(20)30600-9
  12. Versteegen, Pauline; Valente Pinto, Marta; Barkoff, Alex M.; van Gageldonk, Pieter G.M.; van de Kassteele, Jan; van Houten, Marlies A.; Sanders, Elisabeth A.M.; et al. "Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom". EBioMedicine 65 (2021): 103247. http://dx.doi.org/10.1016/j.ebiom.2021.103247.
    10.1016/j.ebiom.2021.103247
  13. Valente Pinto, Marta; Davis, Kimberly; Andrews, Nick; Goldblatt, David; Borrow, Ray; Southern, Jo; Nordgren, Ida Karin; et al. "Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testing". Vaccine 38 49 (2020): 7834-7841. http://dx.doi.org/10.1016/j.vaccine.2020.10.023.
    10.1016/j.vaccine.2020.10.023
  14. O’Connor, Daniel; Pinto, Marta Valente; Sheerin, Dylan; Tomic, Adriana; Drury, Ruth E; Channon-Wells, Samuel; Galal, Ushma; et al. "Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine". Molecular Systems Biology 16 11 (2020): http://dx.doi.org/10.15252/msb.20209888.
    10.15252/msb.20209888
  15. Valente Pinto, Marta; O’Connor, Daniel; Galal, Ushma; Clutterbuck, Elizabeth A; Robinson, Hannah; Plested, Emma; Bibi, Sagida; et al. "Immunogenicity and Reactogenicity of a Reduced Schedule of a 4-component Capsular Group B Meningococcal Vaccine: A Randomized Controlled Trial in Infants". Open Forum Infectious Diseases 7 5 (2020): http://dx.doi.org/10.1093/ofid/ofaa143.
    10.1093/ofid/ofaa143
  16. Valente Pinto, Marta. "The COVID-19 Pandemic: Can it Play a Role in Vaccine Acceptance or Contribute to Vaccine Hesitancy?". (2020): https://doi.org/10.25754/pjp.2020.20445.
    https://doi.org/10.25754/pjp.2020.20445
  17. Goldblatt, David; Southern, Jo; Andrews, Nick J; Burbidge, Polly; Partington, Jo; Roalfe, Lucy; Valente Pinto, Marta; et al. "Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1¿+¿1) compared with two primary doses and a booster (2¿+¿1) in UK infants: a multicentre, parallel group randomised controlled trial". The Lancet Infectious Diseases 18 2 (2018): 171-179. http://dx.doi.org/10.1016/s1473-3099(17)30654-0.
    10.1016/s1473-3099(17)30654-0
  18. Pinto, Marta V.; Merkel, Tod J.. "Pertussis disease and transmission and host responses: insights from the baboon model of pertussis". Journal of Infection 74 (2017): S114-S119. http://dx.doi.org/10.1016/s0163-4453(17)30201-3.
    10.1016/s0163-4453(17)30201-3
  19. Rodrigues, Charlene M.C.; Pinto, Marta V.; Sadarangani, Manish; Plotkin, Stanley A.. "Whither vaccines?". Journal of Infection 74 (2017): S2-S9. http://dx.doi.org/10.1016/s0163-4453(17)30184-6.
    10.1016/s0163-4453(17)30184-6
  20. Pinto, Marta Valente; Bihari, Smiti; Snape, Matthew D.. "Immunisation of the immunocompromised child". Journal of Infection 72 (2016): S13-S22. http://dx.doi.org/10.1016/j.jinf.2016.04.017.
    10.1016/j.jinf.2016.04.017
  21. Leivers, C.; Martin, G.; Gasparetto, M.; Shelley, H.; Valente, M.. "Coeliac disease". Paediatrics and Child Health 24 11 (2014): 481-484. http://dx.doi.org/10.1016/j.paed.2014.05.004.
    10.1016/j.paed.2014.05.004
  22. Valente Pinto, M.; Esteves, I.; Bryceson, Y.; Ferrao, A.. "Hemophagocytic syndrome with atypical presentation in an adolescent". Case Reports 2013 sep11 1 (2013): bcr2013200929-bcr2013200929. http://dx.doi.org/10.1136/bcr-2013-200929.
    10.1136/bcr-2013-200929
Atividades

Consultoria / Parecer

Descrição da atividade Instituição / Organização
2022/07/15 - Atual Presidente da Comissão Técnica da Vacinação da Direção-Geral de Saúde
Distinções

Prémio

2006 Bolsa de Mérito para as 3 melhores classificações da Faculdade de Medicina da Universidade de Lisboa